OLFERA CORP — National Aeronautics and Space Administration STTR Phase I: PARKINSON'S DRUG DISCOVERY ACCELERATED WITH OLFACTORY BRAIN-ON-CHIP ON EARTH AND IN MICROG
OLFERA CORP — STTR Phase I award from National Aeronautics and Space Administration.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from National Aeronautics and Space Administration in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $225,000. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical, Space & Satellite. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Olfera Corp received a $225,000 NASA STTR Phase I award to speed up Parkinson's drug discovery. The project uses an olfactory brain-on-chip model tested on Earth and in microgravity.
- Amount
- $225,000
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- STTR · Phase I
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CA
- Period
- 2026-09-30 → 2027-10-29
Technology domains
Description
STTR PHASE I PARKINSON'S DRUG DISCOVERY ACCELERATED WITH OLFACTORY BRAIN-ON-CHIP ON EARTH AND IN MICROGRAVITY